“Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer”., Radiol Oncol, vol. 56, no. 2, pp. 259–266, Jul. 2022, Accessed: Sep. 20, 2026. Available: https://radioloncol.com/index.php/ro/article/view/3786